0 249

Cited 0 times in

Reply to: "Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?"

Authors
 Nalee Kim  ;  Jinsil Seong 
Citation
 JOURNAL OF HEPATOLOGY, Vol.73(2) : 468-469, 2020-08 
Journal Title
JOURNAL OF HEPATOLOGY
ISSN
 0168-8278 
Issue Date
2020-08
MeSH
Carcinoma, Hepatocellular* / surgery ; Humans ; Liver Neoplasms* / surgery ; Radiofrequency Ablation* ; Radiosurgery* ; Sorafenib
Full Text
https://www.sciencedirect.com/science/article/pii/S0168827820302294
DOI
10.1016/j.jhep.2020.04.016
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers
Yonsei Authors
Kim, Nalee(김나리) ORCID logo https://orcid.org/0000-0003-4742-2772
Seong, Jin Sil(성진실) ORCID logo https://orcid.org/0000-0003-1794-5951
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190039
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links